Company profile for QBiotics Group

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

QBiotics is an Australian life sciences company founded in 2004, that is inspired by nature to improve human and animal health. Our research and development program is based on compounds derived from the Australian tropical rainforest. Our product focus addresses unmet medical needs for humans and companion animals. We are currently concentrating on the global health priority areas of cancer, specifically solid tumours, and ch...
QBiotics is an Australian life sciences company founded in 2004, that is inspired by nature to improve human and animal health. Our research and development program is based on compounds derived from the Australian tropical rainforest. Our product focus addresses unmet medical needs for humans and companion animals. We are currently concentrating on the global health priority areas of cancer, specifically solid tumours, and chronic wound management. Our oncology product, tigilanol tiglate (EBC-46), is a new approach to the treatment of solid tumour cancers.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
Australia
Address
Address
PO Box 42 Toowong BC, 4066 QLD
Telephone
Telephone
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.prnewswire.com/news-releases/qbiotics-reports-80-objective-response-rate-in-injected-tumours-in-stage-1-of-phase-iia-clinical-trial-of-tigilanol-tiglate-for-soft-tissue-sarcoma-302490653.html

PR NEWSWIRE
25 Jun 2025

https://www.prnewswire.com/news-releases/qbiotics-welcomes-stephen-doyle-as-chief-executive-officer-302214171.html

PR NEWSWIRE
05 Aug 2024

https://www.prnewswire.com/news-releases/qbiotics-to-present-at-sachs-9th-annual-immuno-oncology-innovation-forum-and-the-bio-international-convention-301838291.html

PR NEWSWIRE
31 May 2023

https://www.prnewswire.com/news-releases/new-cancer-treatment-for-australian-dogs-with-apvma-approval-of-qbiotics-stelfonta-301326433.html

PR NEWSWIRE
07 Jul 2021

https://www.prnewswire.com/news-releases/new-cancer-treatment-for-australian-dogs-with-apvma-approval-of-qbiotics-stelfonta-301326433.html

PR NEWSWIRE
07 Jul 2021

http://www.pharmabiz.com/NewsDetails.aspx?aid=130406&sid=2

PHARMABIZ
14 Aug 2020

REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty